Expansion of Molecular and Clinical Aspects of EPS8L2 (DFNB106)-Associated Hearing Loss Emphasizes a Potential Therapeutic Window
Daniel Owrang(German Primate Center), Barbara Vona(Broad Institute), Susanne M. Kolb(University of Würzburg), Michaela A. H. Hofrichter(University of Würzburg), Shahrooz Ghaderi(Universitätsmedizin Göttingen), Julia Doll(University of Würzburg), Sheng‐Jia Lin(Oklahoma Medical Research Foundation), Neda Alidadiani, Masoome Alerasool(Mashhad University of Medical Sciences), Aboulfazl Rad(Sabzevar University of Medical Sciences), Reza Maroofian(National Hospital for Neurology and Neurosurgery), Thomas Haaf(University of Würzburg), Oliver Bartsch(Johannes Gutenberg University Mainz), Gaurav K. Varshney(Oklahoma Medical Research Foundation)
Cited by 0
Related Papers
Satisfaction with Genital Surgery and Sexual Life of Adults with XY Disorders of Sex Development: Results from the German Clinical Evaluation Study
|The Journal of Clinical Endocrinology & Metabolism|2011|178
Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations
|Journal of Allergy and Clinical Immunology|2020|127
<scp>DFNB16</scp> is a frequent cause of congenital hearing impairment: implementation of <i><scp>STRC</scp></i> mutation analysis in routine diagnostics
|Clinical Genetics|2013|110
Non-syndromic hearing loss gene identification: A brief history and glimpse into the future
|Molecular and Cellular Probes|2015|109
Targeted next-generation sequencing of deafness genes in hearing-impaired individuals uncovers informative mutations
|Genetics in Medicine|2014|107